Use of monoclonal antibodies (mAbs) and their future prospects
MODERN ISSUES OF MEDICINE AND MANAGEMENT · 2022
DOI: 10.56580/geomedi0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift MODERN ISSUES OF MEDICINE AND MANAGEMENT, 2022. Verfasst von Marina Pirtskhalava und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The article discusses the areas of use of monoclonal antibodies (mAbs) and prospects for future use. The effectiveness of monoclonal antibodies in the modern stage, against diseases of different etiology, provides the basis for the assumption that in the future it will be further refined to obtain monoclonal antibodies, which will contribute to its widespread use not only in the treatment of diseases, but also in diagnostics.
Zitieren
APA
Pirtskhalava, M., Vakhania, M., Mindiashvili, T., Kobiashvili, M., & Velijanashvili, M. (2022). Use of monoclonal antibodies (mAbs) and their future prospects. MODERN ISSUES OF MEDICINE AND MANAGEMENT. https://doi.org/10.56580/geomedi0001
Vancouver
Pirtskhalava M, Vakhania M, Mindiashvili T, Kobiashvili M, Velijanashvili M. Use of monoclonal antibodies (mAbs) and their future prospects. MODERN ISSUES OF MEDICINE AND MANAGEMENT. 2022. doi:10.56580/geomedi0001
BibTeX
@article{Pirtskhalava2022,
author = {Pirtskhalava, Marina and Vakhania, Malkhaz and Mindiashvili, Tornike and Kobiashvili, Mariam and Velijanashvili, Mariam},
title = {Use of monoclonal antibodies (mAbs) and their future prospects},
journal = {MODERN ISSUES OF MEDICINE AND MANAGEMENT},
year = {2022},
doi = {10.56580/geomedi0001}
}
EUVIMED